Marissa S. Pioso

Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy

A. Ribas, A. Drakaki, T. Angell, 2021, bioRxiv.

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, G. Cavaletti, 2018, The Journal of clinical investigation.

Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana.

A. Khamesipour, A. Satoskar, S. Varikuti, 2017, Acta tropica.

STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade

Greta Volpedo, A. Satoskar, R. Ganju, 2017, Oncoimmunology.

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML

Christina D Drenberg, R Kiplin Guy, A. Shelat, 2019, Nature Communications.

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia.

Annette S. Kim, A. Letai, C. Paweletz, 2020, Cancer cell.

High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors

A. Letai, Jean J. Zhao, A. Aguirre, 2020, Science Signaling.

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML

A. Shelat, R. Guy, R. Ribeiro, 2019, Nature Communications.

Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy

A. Ribas, A. Drakaki, Willy Hugo, 2022, The Journal of Immunology.

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity

Lara E Sucheston-Campbell, G. Cavaletti, A. Gibson, 2018, The Journal of clinical investigation.